###
中国临床研究:2023,36(7):961-964
←前一篇   |   后一篇→
本文二维码信息
码上扫一扫!
“医工交叉”背景下妇科肿瘤领域的“产学研用”
(东南大学附属中大医院妇产科,江苏 南京 210009)
The crosstalk between “industry university research application” and “medical engineering” in gynecological oncology
(Department of Obstetrics and Gynaecology, Zhongda Hospital, Southeast University, Nanjing, Jiangsu 210009, China)
摘要
本文已被:浏览 1523次   下载 396
投稿时间:2022-12-07   网络发布日期:2023-07-19
中文摘要: 根据“健康中国2030”的战略要求,“医工交叉”在妇科肿瘤领域的研究潜力巨大。本文从细胞工程、生物材料工程、机械工程、人工智能四个主要角度述评了“医工交叉”在妇科肿瘤领域的代表性成果,并以人工智能辅助——液基薄层细胞检测(TCT)扫描分析系统的开发为例,阐述了“产学研用”的实现过程。实施“医工交叉”不只是对妇科肿瘤领域的利好,也是传统工科焕发新活力的重要途径,更是医学发展升级的必由之路。随着政策落地、市场认可和技术转化等方面逐步成熟,“医工交叉”也将迎来黄金投资期,实现真正意义的“产学研用”。
Abstract:According to the strategic requirement of “Health China 2030”, “medical and industrial intersection” has great research potential of in the field of gynecological oncology. The comment reviews the representative achievements of four main perspectives in medical engineering: cell engineering, biomaterials engineering, mechanical engineering and artificial intelligence in gynecological tumors. The process of industry university research application(IURA) is illustrated by the development of artificial intelligence assisted TCT scan analysis system. The implementation of medical engineering is not only beneficial to gynecological oncology, but also an important way to renew the vitality of traditional engineering, and a necessary way to upgrade medical filed. With the maturity of policy, market and technology, medical engineering intersection will also usher in an investment period and realize the IURA.
文章编号:     中图分类号:R737.3 R-4    文献标志码:A
基金项目:国家自然科学基金(82072078);江苏省重点研发计划(SBE2020741118);江苏省卫生健康委科研项目(ZDA2020012)
引用文本:
冯嵩崴,沈杨.“医工交叉”背景下妇科肿瘤领域的“产学研用”[J].中国临床研究,2023,36(7):961-964.

用微信扫一扫

用微信扫一扫